vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
Open | $24.630 |
Close | $25.500 |
Volume / Avg. | 5.602K / 69.792K |
Day Range | 24.005 - 25.500 |
52 Wk Range | 7.380 - 39.600 |
Market Cap | $61.381M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 2.15% |
Days to Cover | 1.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to fall to within 12 months (a possible -76.22% downside). 0 analyst firms have reported ratings in the last year.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $25.23 last updated April 24, 2024 at 7:32 PM EDT.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.